PYCARD and prostate cancer: Using the methyl-CpG targeted transcriptional activation (MeTA) method, we identified apoptosis-inducing PYCARD as a DNA hypermethylation-mediated silencing gene, particularly in prostate cancer with Gleason score ≥ 7.